Back

Results - Announcements

Sales rise 34.77% to Rs 429.88 crore

Concord Biotech consolidated net profit rises 47.75% in the March 2025 quarter

30-May-2025, 07:41
Net profit of Concord Biotech rose 47.75% to Rs 140.39 crore in the quarter ended March 2025 as against Rs 95.02 crore during the previous quarter ended March 2024. Sales rose 34.77% to Rs 429.88 crore in the quarter ended March 2025 as against Rs 318.97 crore during the previous quarter ended March 2024.

For the full year,net profit rose 20.62% to Rs 371.64 crore in the year ended March 2025 as against Rs 308.10 crore during the previous year ended March 2024. Sales rose 18.01% to Rs 1200.09 crore in the year ended March 2025 as against Rs 1016.94 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	429.88	318.97	35	1200.09	1016.94	18
OPM %	43.94	41.41	-	42.08	42.44	-
PBDT	198.16	142.44	39	548.93	466.16	18
PBT	183.54	128.72	43	494.55	412.57	20
NP	140.39	95.02	48	371.64	308.10	21